Xolair 150 MG/ML syringeml

Ended Awarded

Contract number
SPE2DB23FX7T3
Awardee
Awarding agency
Obligated
$8,124

Award facts

Contract value 100% obligated
$8,123.85 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Park Ridge, IL 60068, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency (DOD) awarded a $8,123.85 firm fixed price delivery order to DMS Pharmaceutical Group Inc. for the product "XOLAIR 150 MG/ML SYRINGEML." The place of performance will be in Park Ridge, Illinois. The period of performance is from July 26, 2023 through August 16, 2023. As the DLA supports the logistical needs of the military services, this contract for syringes of the medication Xolair is likely to support treatment of allergic or inflammatory conditions for military personnel under the DLA's medical supply chain responsibilities. No subcontractors or set aside designations were identified in the award information provided.

Quick answers

Who was awarded contract SPE2DB23FX7T3?

SPE2DB23FX7T3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 26, 2023.

How much is contract SPE2DB23FX7T3 worth?

The government has obligated $8,124 on SPE2DB23FX7T3.

Is contract SPE2DB23FX7T3 an order under another contract?

Yes. SPE2DB23FX7T3 is a delivery order under SPE2DB20D9354, an indefinite delivery contract.

Was contract SPE2DB23FX7T3 competed?

The extent of competition for SPE2DB23FX7T3 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award